Literature DB >> 24825253

Socioeconomic status and the risk for being diagnosed with spondyloarthritis and chronic pain: a nested case-control study.

Anna Jöud1, Ingemar F Petersson, Kelvin P Jordan, Sofia Löfvendahl, Birgitta Grahn, Martin Englund.   

Abstract

Socioeconomic status could potentially impact on which type of rheumatic diagnosis a patient receives. We determined whether different socioeconomic status is a risk factor for being diagnosed with spondyloarthritis (SpA) or chronic pain. In a nested case-control study, we identified two sets of adult cases diagnosed with (i) SpA (n = 1,194) and (ii) chronic pain (n = 3,730) during 2010-2012 in Skåne region, Sweden. We randomly sampled controls matched for age and sex. Level of education, marital status, and income were identified in national registers 4 years before inclusion. We also studied health-care utilization, prescribed pharmaceuticals, and work status. We used conditional logistic regressions and included socioeconomic variables and geographic area in the models. Low (odds ratio [OR] 1.69 95 % CI 1.50-1.91) or moderate education (OR 1.43 95 % CI 1.30-1.57), and low (OR 1.40 95 % CI 1.25-1.57) or moderate income (OR 1.24 95 % CI 1.10-1.38) were associated with a chronic pain diagnosis. For a SpA diagnosis, moderate income (OR 1.25 95 % CI 1.04-1.50) was the only significant factor identified. Both case groups had a larger proportion that did not work (P < 0.001), used more health care (P < 0.001), and were more frequently prescribed NSAIDs (P < 0.001) 4 years before diagnosis than controls. We confirmed that lower levels of education and income are associated with a chronic pain diagnosis. This association may reflect a true higher incidence of chronic pain and/or increased consultation propensity for such pain in people with socioeconomic status. We found no such association for SpA.

Entities:  

Mesh:

Year:  2014        PMID: 24825253     DOI: 10.1007/s00296-014-3039-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

1.  Equity in the delivery of health care in Europe and the US.

Authors:  E van Doorslaer; A Wagstaff; H van der Burg; T Christiansen; D De Graeve; I Duchesne; U G Gerdtham; M Gerfin; J Geurts; L Gross; U Häkkinen; J John; J Klavus; R E Leu; B Nolan; O O'Donnell; C Propper; F Puffer; M Schellhorn; G Sundberg; O Winkelhake
Journal:  J Health Econ       Date:  2000-09       Impact factor: 3.883

2.  Explaining income-related inequalities in doctor utilisation in Europe.

Authors:  Eddy van Doorslaer; Xander Koolman; Andrew M Jones
Journal:  Health Econ       Date:  2004-07       Impact factor: 3.046

Review 3.  The impact and burden of chronic pain in the workplace: a qualitative systematic review.

Authors:  Ajay S Patel; Rachel Farquharson; Dawn Carroll; Andrew Moore; Ceri J Phillips; Rod S Taylor; Jodie Barden
Journal:  Pain Pract       Date:  2012-03-29       Impact factor: 3.183

4.  Work productivity in a population-based cohort of patients with spondyloarthritis.

Authors:  Emma Haglund; Ann Bremander; Stefan Bergman; Lennart T H Jacobsson; Ingemar F Petersson
Journal:  Rheumatology (Oxford)       Date:  2013-06-25       Impact factor: 7.580

5.  Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study.

Authors:  S Bergman; P Herrström; K Högström; I F Petersson; B Svensson; L T Jacobsson
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

6.  Epidemiology of spondyloarthritis in Argentina.

Authors:  Emilio Buschiazzo; Jose A Maldonado-Cocco; Pablo Arturi; Gustavo Citera; Alberto Berman; Alejandro Nitsche; Oscar L Rillo
Journal:  Am J Med Sci       Date:  2011-04       Impact factor: 2.378

7.  The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.

Authors:  Syed Imran Haider; Kristina Johnell; Gunilla Ringbäck Weitoft; Mats Thorslund; Johan Fastbom
Journal:  J Am Geriatr Soc       Date:  2008-11-14       Impact factor: 5.562

8.  Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization.

Authors:  H I Andersson; G Ejlertsson; I Leden; C Rosenberg
Journal:  Clin J Pain       Date:  1993-09       Impact factor: 3.442

9.  Socioeconomic status, structural and functional measures of social support, and mortality: The British Whitehall II Cohort Study, 1985-2009.

Authors:  Silvia Stringhini; Lisa Berkman; Aline Dugravot; Jane E Ferrie; Michael Marmot; Mika Kivimaki; Archana Singh-Manoux
Journal:  Am J Epidemiol       Date:  2012-04-24       Impact factor: 4.897

10.  Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Authors:  Jan Sørensen; Merete Lund Hetland
Journal:  Ann Rheum Dis       Date:  2014-02-17       Impact factor: 19.103

View more
  4 in total

1.  Drinking cultures and socioeconomic risk factors for alcohol and drug use disorders among first- and second-generation immigrants: A longitudinal analysis of Swedish population data.

Authors:  Won Kim Cook; Xinjun Li; Kristina Sundquist; Kenneth S Kendler; Jan Sundquist; Katherine J Karriker-Jaffe
Journal:  Drug Alcohol Depend       Date:  2021-06-18       Impact factor: 4.852

2.  Familial Risk of Chronic Musculoskeletal Pain and the Importance of Physical Activity and Body Mass Index: Prospective Data from the HUNT Study, Norway.

Authors:  Ragnhild Lier; Paul Jarle Mork; Andreas Holtermann; Tom Ivar Lund Nilsen
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

3.  The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.

Authors:  Nicole Atkins; Karim Mukhida
Journal:  Can J Pain       Date:  2022-09-01

4.  The association between the socioeconomic status and body pain: A nationwide survey.

Authors:  Tong Yu; Zhen Wei; Tan Xu; Michelle Gamber; Jingnan Han; Yan Jiang; Jian Li; Daihe Yang; Wenjie Sun
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.